LAVA Therapeutics NV (LVTX) — Cash Flow Reinvestment Rate
LAVA Therapeutics NV (LVTX) has a Cash Flow Reinvestment Rate of 0.12x as of December 2022, reinvesting $4.40 Million (capex $265.00K plus investments $-4.14 Million) from operating cash flow of $35.73 Million. Check LVTX operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
LAVA Therapeutics NV Cash Flow Reinvestment Rate (2022–2022)
Historical reinvestment intensity for LAVA Therapeutics NV across 1 annual periods. Explore LAVA Therapeutics NV debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for LAVA Therapeutics NV (2022–2022)
Year-by-year capital reinvestment analysis for LAVA Therapeutics NV. For live market cap and broader valuation context, see how much is LAVA Therapeutics NV worth.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 2.46x | $9.93 Million | $4.04 Million | $587.00K | — |